What is Until Labs?
Until Labs is at the forefront of biological innovation, developing groundbreaking technology to pause biological time. The company leverages an in-house team comprising biologists, engineers, and physicists to prototype and scale advanced cryopreservation methods. This interdisciplinary approach is critical for advancing the field of suspended animation and related life-extension technologies.
How much funding has Until Labs raised?
Until Labs has raised a total of $58M across 1 funding round:
Series A
$58M
Series A (2025): $58M with participation from Lux Capital and Founders Fund
Key Investors in Until Labs
Lux Capital
Lux Capital is a New York-based venture capital firm specializing in early-stage and growth-stage companies at the intersection of science and technology, backing founders in frontier areas such as AI, robotics, space, defense, biotechnology, and advanced materials.
Founders Fund
Founders Fund invests in the world's most important and valuable companies across all geographies, sectors and stages, providing maximum support with minimum interference to founders.
What's next for Until Labs?
With this major enterprise-level funding, Until Labs is poised for significant expansion and further research and development. The strategic investment will likely accelerate the scaling of their cryopreservation technologies and potentially enable broader applications beyond initial prototypes. The company's focus on a complex scientific challenge suggests a long-term vision, with future growth potentially involving further funding rounds to support clinical trials, regulatory approvals, and market penetration.
See full Until Labs company page
